secwatch.observer — SEC 8-K summary
======================================

Issuer:     HCW Biologics Inc. (HCWB)
CIK:        0001828673
Form:       8-K
Filed at:   2025-12-31T23:59:59+00:00
Accession:  0001193125-25-338026
Event type: regulatory
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

HCW Biologics reports equity above $2.5M after deals; awaits Nasdaq compliance decision
--------------------------------------------------------------------------------

- Warrant inducement netted $3.8M; holders exercised 1.51M shares at $2.66, received new warrants at $2.41.
- Issued shares under standby equity line in Q4 2025 for net proceeds of $363,858, boosting equity.
- Settled $7.4M legal fees for $2.0M cash ($500K paid, $1.5M due on license fee receipt); expects $5.4M equity gain.
- Company states stockholders' equity now exceeds $2.5M minimum; awaits Nasdaq formal verification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828673/000119312525338026/0001193125-25-338026-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828673/000119312525338026/hcwb-20251230.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-338026

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer